Using a special dye to see prostate cancer during surgery
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a dye that makes prostate cancer cells glow during robot-assisted surgery. The goal is to help surgeons remove all the cancer while protecting healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer that was confirmed by a biopsy.
- You are scheduled for robot-assisted surgery to remove your prostate.
- You are 18 years or older.
- Your cancer has a Gleason score of 7 or higher, or imaging shows it is stage T2 or above.
- Your liver and kidneys are working well enough (blood tests will check).
- You have not had hormone therapy, radiation, or other cancer treatments in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug (BMS-986365) combined with another hormone therapy (degarelix) before radical prostatectomy for high-risk prostate cancer. The goal is to see if this combination helps lower cancer activity before surgery.
This trial tests a new dye (AS1986NS) that sticks to prostate cancer cells during a biopsy. It aims to help doctors see cancer more clearly. You may be able to join if you are scheduled for a standard prostate biopsy and have no major health issues.
This trial tests whether a new imaging technique (PSMA-PET/MRI fused with ultrasound) helps surgeons perform more precise robotic prostate removal in men with prostate cancer that has started to spread outside the gland. It aims to improve cancer control and reduce side effects.
This trial compares two radioactive drugs (177Lu-PSMA-617 and 225Ac-PSMA-617) given before prostate removal surgery in men with high-risk prostate cancer that has not spread far. The goal is to see which drug is better at shrinking the tumor and reducing the chance of cancer coming back.
This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.
This Phase 1 study tests nanoparticles (tiny particles) that are meant to help surgeons better find and remove prostate cancer tissue during surgery. You may be offered standard prostate surgery plus imaging with a study tracer to guide the operation.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.